
|Articles|September 30, 2004
Group files complaint with FTC over sex supplement ads
A leading consumer advocacy group has filed a complaint with the Federal Trade Commission over what it says is deceptive advertising of a nutritional supplement known as Enzyte, which is designed to improve erectile function.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











